The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience (original) (raw)

References

  1. Marko NF, Weil RJ, Schroeder JL, Lang FF, Suki D, Sawaya RE (2014) Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. J Clin Oncol 32(8):774–782. https://doi.org/10.1200/jco.2013.51.8886
    Article PubMed PubMed Central Google Scholar
  2. Orringer D, Lau D, Khatri S, Zamora-Berridi GJ, Zhang K, Wu C, Chaudhary N, Sagher O (2012) Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. J Neurosurg 117(5):851–859. https://doi.org/10.3171/2012.8.Jns12234
    Article PubMed Google Scholar
  3. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115(1):3–8. https://doi.org/10.3171/2011.2.Jns10998
    Article PubMed Google Scholar
  4. Eljamel S (2015) 5-ALA fluorescence image guided resection of glioblastoma multiforme: a meta-analysis of the literature. Int J Mol Sci 16(5):10443–10456. https://doi.org/10.3390/ijms160510443
    Article CAS PubMed PubMed Central Google Scholar
  5. Gessler F, Forster MT, Duetzmann S, Mittelbronn M, Hattingen E, Franz K, Seifert V, Senft C (2015) Combination of intraoperative magnetic resonance imaging and intraoperative fluorescence to enhance the resection of contrast enhancing gliomas. Neurosurgery 77(1):16–22. https://doi.org/10.1227/neu.0000000000000729 (Discussion 22)
    Article PubMed Google Scholar
  6. Jenkinson MD, Barone DG, Bryant A, Vale L, Bulbeck H, Lawrie TA, Hart MG, Watts C (2018) Intraoperative imaging technology to maximise extent of resection for glioma. The Cochrane database of systematic reviews. 1:Cd012788. https://doi.org/10.1002/14651858.CD012788.pub2
  7. Kittle D, Mamelak A, Parrish-Novak J, Hansen S, Patil R, Wadhone-Gangalum P, Ljubimova J, Black KL, Butte P (2014) Fluorescence-guided tumor visualization using the tumor paint BLZ-100. Cureus. https://doi.org/10.7759/cureus.210
    Article Google Scholar
  8. Prada F, Bene MD, Fornaro R, Vetrano IG, Martegani A, Aiani L, Sconfienza LM, Mauri G, Solbiati L, Pollo B, DiMeco F (2016) Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection. Neurosurg Focus 40(3):E7. https://doi.org/10.3171/2015.11.Focus15573
    Article PubMed Google Scholar
  9. Stummer W, Suero Molina E (2017) Fluorescence imaging/agents in tumor resection. Neurosurg Clin N Am 28(4):569–583. https://doi.org/10.1016/j.nec.2017.05.009
    Article PubMed Google Scholar
  10. Yamada S, Muragaki Y, Maruyama T, Komori T, Okada Y (2015) Role of neurochemical navigation with 5-aminolevulinic acid during intraoperative MRI-guided resection of intracranial malignant gliomas. Clin Neurol Neurosurg 130:134–139. https://doi.org/10.1016/j.clineuro.2015.01.005
    Article PubMed Google Scholar
  11. Marbacher S, Klinger E, Schwyzer L, Fischer I, Nevzati E, Diepers M, Roelcke U, Fathi AR, Coluccia D, Fandino J (2014) Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases. Neurosurg Focus 36(2):E10. https://doi.org/10.3171/2013.12.Focus13464
    Article PubMed Google Scholar
  12. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz AE, Kiefmann R, Reulen HJ (1998) Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42(3):518–525 (Discussion 525–516)
    Article CAS PubMed Google Scholar
  13. CHMP (2007) Gliolan; INN 5-aminolevulinic hydrochloric acid scientific discussion. London, UK. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000744/WC500021788.pdf
  14. Hadley MN, Walters BC, Grabb PA, Oyesiku NM, Przybylski GJ, Resnick DK, Ryken TC (2002) Methodology of guideline development. Neurosurgery 50(3 Suppl):S2–S6. https://doi.org/10.1097/00006123-200203001-00004
    Article CAS PubMed Google Scholar
  15. Eyupoglu IY, Hore N, Savaskan NE, Grummich P, Roessler K, Buchfelder M, Ganslandt O (2012) Improving the extent of malignant glioma resection by dual intraoperative visualization approach. PloS ONE 7(9):e44885. https://doi.org/10.1371/journal.pone.0044885
    Article CAS PubMed PubMed Central Google Scholar
  16. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401. https://doi.org/10.1016/s1470-2045(06)70665-9
    Article CAS PubMed Google Scholar
  17. Coburger J, Hagel V, Wirtz CR, Konig R (2015) Surgery for glioblastoma: impact of the combined use of 5-aminolevulinic acid and intraoperative MRI on extent of resection and survival. PloS ONE 10(6):e0131872. https://doi.org/10.1371/journal.pone.0131872
    Article CAS PubMed PubMed Central Google Scholar
  18. Schatlo B, Fandino J, Smoll NR, Wetzel O, Remonda L, Marbacher S, Perrig W, Landolt H, Fathi AR (2015) Outcomes after combined use of intraoperative MRI and 5-aminolevulinic acid in high-grade glioma surgery. Neuro-oncology 17(12):1560–1567. https://doi.org/10.1093/neuonc/nov049
    Article CAS PubMed PubMed Central Google Scholar
  19. Roder C, Bisdas S, Ebner FH, Honegger J, Naegele T, Ernemann U, Tatagiba M (2014) Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery. Eur J Surg Oncol 40(3):297–304. https://doi.org/10.1016/j.ejso.2013.11.022
    Article CAS PubMed Google Scholar
  20. Kim SK, Choi SH, Kim YH, Park C-K (2014) Impact of fluorescence-guided surgery on the improvement of clinical outcomes in glioblastoma patients. Neurooncol Pract 1(3):81–85. https://doi.org/10.1093/nop/npu011
    Article PubMed PubMed Central Google Scholar
  21. Kaufman MB (2017) Pharmaceutical approval update. Pharm Ther 42(11):673–683
    Google Scholar
  22. Della Puppa A, Ciccarino P, Lombardi G, Rolma G, Cecchin D, Rossetto M (2014) 5-Aminolevulinic acid fluorescence in high grade glioma surgery: surgical outcome, intraoperative findings, and fluorescence patterns. BioMed Res Int 2014:232561. https://doi.org/10.1155/2014/232561
    Article CAS PubMed Google Scholar
  23. Tsugu A, Ishizaka H, Mizokami Y, Osada T, Baba T, Yoshiyama M, Nishiyama J, Matsumae M (2011) Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. World Neurosur 76(1–2):120–127. https://doi.org/10.1016/j.wneu.2011.02.005
    Article Google Scholar
  24. Teixidor P, Arraez MA, Villalba G, Garcia R, Tardaguila M, Gonzalez JJ, Rimbau J, Vidal X, Montane E (2016) Safety and efficacy of 5-aminolevulinic acid for high grade glioma in usual clinical practice: a prospective cohort study. PloS ONE 11(2):e0149244. https://doi.org/10.1371/journal.pone.0149244
    Article CAS PubMed PubMed Central Google Scholar
  25. Cozzens JW, Lokaitis BC, Moore BE, Amin DV, Espinosa JA, MacGregor M, Michael AP, Jones BA (2017) A phase 1 dose-escalation study of oral 5-aminolevulinic acid in adult patients undergoing resection of a newly diagnosed or recurrent high-grade glioma. Neurosurgery 81(1):46–55. https://doi.org/10.1093/neuros/nyw182
    Article PubMed Google Scholar
  26. Stummer W, Stepp H, Wiestler OD, Pichlmeier U (2017) Randomized, prospective double-blinded study comparing 3 different doses of 5-aminolevulinic acid for fluorescence-guided resections of malignant gliomas. Neurosurgery 81(2):230–239. https://doi.org/10.1093/neuros/nyx074
    Article PubMed PubMed Central Google Scholar
  27. Diez Valle R, Tejada Solis S, Idoate Gastearena MA, Garcia de Eulate R, Dominguez Echavarri P, Aristu Mendiroz J (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol 102(1):105–113. https://doi.org/10.1007/s11060-010-0296-4
    Article CAS PubMed Google Scholar
  28. Idoate MA, Diez Valle R, Echeveste J, Tejada S (2011) Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence. Neuropathology 31(6):575–582. https://doi.org/10.1111/j.1440-1789.2011.01202.x
    Article PubMed Google Scholar
  29. Roberts DW, Valdes PA, Harris BT, Fontaine KM, Hartov A, Fan X, Ji S, Lollis SS, Pogue BW, Leblond F, Tosteson TD, Wilson BC, Paulsen KD (2011) Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between delta-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. J Neurosurg 114(3):595–603. https://doi.org/10.3171/2010.2.Jns091322
    Article PubMed Google Scholar

Download references